ReviewCureus2025
Use of Damage Control Surgery and Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in Penetrating Torso Trauma: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- War-related penetrating cervicothoracic trauma managed in a resource-limited hospital in Syria: a case series.International journal of emergency medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penetrating torso trauma, often complicated by non-compressible torso hemorrhage (NCTH), is a leading cause of preventable death. Damage control surgery (DCS) is standard care, with resuscitative endovascular balloon occlusion of the aorta (REBOA) emerging as a minimally invasive adjunct for temporary hemorrhage control. This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-guided systematic review included six studies with a total of 2,705 patients, comparing combined DCS and REBOA with DCS alone or alternative strategies. Several studies indicated improved survival and faster hemorrhage control, while others reported higher control rates compared to resuscitative thoracotomy. Conversely, some data suggested increased mortality and complications in penetrating abdominal vascular injuries. Pooled findings suggested a potential survival benefit, but heterogeneity and confounding limited certainty. Reported risks included ischemia-reperfusion injury, limb ischemia, and increased transfusion requirements. REBOA may improve outcomes in selected patients, but its benefit appears context-dependent, warranting prospective trials to refine indications and timing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.